Evidence map›Paper›PMID 40636513›Full record

ArticleFrontiers in pediatrics2025

The "gray zone" in pediatric end-of-life care: bioethical and medico-legal reflections.

Roberto Scendoni, Francesco De Micco

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Roberto ScendoniDepartment of Law, Institute of Legal Medicine, University of Macerata, Macerata, Italy.
Francesco De MiccoResearch Unit of Bioethics and Humanities, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Palliative care for children with incurable diseases represents one of the most complex challenges in pediatric medicine. It requires a delicate balance between continuing potentially ineffective therapies and ensuring comfort and dignity during the terminal phase. Decisions involve both the family and the medical team, with a particular focus on the "gray zone," where prognostic uncertainty makes it difficult to determine the most ethical course of action. According to the WHO, palliative care aims to improve the quality of life for both the child and their family, addressing not only physical pain but also psychological and social issues. This article explores the bioethical and medico-legal implications surrounding end-of-life care, parental decision-making autonomy, and the need to always prioritize the child's best interests, while respecting their dignity and values.

Indexed as

bioethicsdeathend-of-life decisionpalliative carepediatrics

Identifiers

PMID40636513
PMCPMC12237892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.